header-aidsvaccine

HIV Orange
AIDS Vaccine Basics is comprised of our popular Primer series, textbook-like chapters of about 800 words each that aim to translate the complex world of AIDS vaccine science into simple but informative language. Here you will find deftly written explanations on how different AIDS vaccine strategies work, what cells comprise the different arms of the human immune system, and how to interpret the results of AIDS vaccine trials. The page contains a searchable key that allows readers to track down Primer topics dating back to 2003.

Understanding Partial Efficacy
VAX-2(4)-May-2004
What is a partially effective vaccine?
Read More »

Understanding if Broadly Neutralizing Antibodies are the Answer
VAX May 2010

Read More »

Understanding Vaccine Development
VAX-2(3)-April-2004
How are vaccines developed?
Read More »

Understanding Advances in the Search for Antibodies Against HIV
VAX March 2010
What are some of the recent developments that are helping researchers identify new targets for HIV vaccine design?
Read More »

Understanding the Immune System, Part II
VAX-2(2)-March-2004
How do AIDS vaccines prepare different parts of the immune system to fight HIV?
Read More »

Understanding Antibody Functions: Beyond Neutralization
VAX January 2010
What other antibody functions are being explored to explain the RV144 results?
Read More »

Understanding Vaccine Licensure
Vax December 2009
What factors do regulatory bodies consider before licensing a vaccine for public use?
Read More »

Understanding the Immune System, Part I
VAX-2(1)-February-2004
How do vaccines interact with the immune system?
Read More »

Understanding the Hunt for Immune Correlates of Protection from RV144
Vax November 2009
How can the recently conducted AIDS vaccine trial in Thailand help inform researchers about the types of immune responses that can provide protection against HIV?
Read More »

Understanding the Statistical Analysis of Clinical Trial Results
Vax October 2009
What are some of the statistical methods that are used to interpret clinical trial results?
Read More »

Understanding Trial Approval
VAX-1(4)-November-2003
How does an AIDS vaccine trial gain official approval and community support?
Read More »

Understanding Challenge Viruses
Vax September 2009
How does the choice of challenge virus affect the outcome of vaccine studies in nonhuman primates?
Read More »

Understanding the Role of Social Science Research in Clinical Trials
Vax August 2009
What can researchers learn from studying communities in preparation for AIDS vaccine clinical trials?
Read More »

Understanding Routes of Transmission
VAX-1(3)-October-2003
Why do vaccines need to be tested in different populations?
Read More »

Understanding Inclusion/Exclusion Criteria
Vax July 2009
What are come of the eligibility requirements for volunteers to participate in AIDS vaccine clinical trials?
Read More »

Understanding Viral Diversity
VAX-1(2)-September-2003
Why are there so many different versions of HIV?
Read More »

Understanding How Data is Collected in Clinical Trials
Vax June 2009
What are the methods used to ensure that data from AIDS vaccine trials are of high quality?
Read More »

Understanding How Partially Effective Vaccine Candidates are Evaluated
Vax May 2009
What are some of the complications in designing trials to study partially effective AIDS vaccine candidates?
Read More »

Understanding Vaccine Trials
VAX-1(1)-August-2003
How are AIDS vaccines tested?
Read More »

Understanding the Transmitted Virus
Vax April 2009
What are researchers learning about the enemy that a preventive AIDS vaccine would need to block—the virus that is transmitted and establishes infection?
Read More »